Breathe Well Live Well
|
Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial …
MarketWatch (press release) ARIDOL should not be used as a stand alone test to assess asthma or as a screening test for asthma, but as part of a physician's overall assessment of asthma. The new J-code becomes effective on January 1, 2012. J-codes are used by providers to bill … |
View full post on asthma – Google News
|
New Kind of Baby Powder
MyNews4 Many moms have stopped using talcum baby powder after doctors found the fine particles can get into a baby's lungs and cause asthma or pneumonia. … Alternative to baby powder on the market Baby Powder Alternative Called Safer By Creator |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Placebo; Drug: Albuterol Spiromax®
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
|
FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial …
Kansas City Star ARIDOL is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Active, not recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Fluticasone propionate inhalation powder; Drug: Fluticasone furoate inhalation powder; Drug: Placebo inhalation powder
Sponsor: GlaxoSmithKline
Recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days